Literature DB >> 18985296

Psychiatric symptoms in Parkinson's disease.

Frank Schneider1, Astrid Althaus, Volker Backes, Richard Dodel.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder which is often reduced to a mere dysfunction of motor performance. Non-motor symptoms, however, are frequent impairments in PD and result in a major impact on the patients and their caregivers. The major neuropsychiatric comorbidities depression, anxiety, and psychotic symptoms are briefly discussed. Additionally, a brief outlook on deep brain stimulation and its effect on psychiatric symptoms is provided. Several studies did show that neuropsychiatric symptoms are underdiagnosed and consecutively treated inadequately. All in all more attention should be directed to the detection and treatment of psychiatric symptoms in PD patients in routine clinical settings.

Entities:  

Mesh:

Year:  2008        PMID: 18985296     DOI: 10.1007/s00406-008-5012-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  40 in total

Review 1.  Depression in Parkinson's disease. An update.

Authors:  W H Oertel; G U Höglinger; T Caraceni; F Girotti; T Eichhorn; A E Spottke; J C Krieg; W Poewe
Journal:  Adv Neurol       Date:  2001

2.  Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.

Authors:  L Castelli; P Perozzo; M Zibetti; B Crivelli; U Morabito; M Lanotte; F Cossa; B Bergamasco; L Lopiano
Journal:  Eur Neurol       Date:  2006-05-08       Impact factor: 1.710

3.  Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease.

Authors:  Frank Schneider; Ute Habel; Jens Volkmann; Sabine Regel; Jürgen Kornischka; Volker Sturm; Hans-Joachim Freund
Journal:  Arch Gen Psychiatry       Date:  2003-03

4.  Increased risk of Parkinson's disease after depression: a retrospective cohort study.

Authors:  A G Schuurman; M van den Akker; K T J L Ensinck; J F M Metsemakers; J A Knottnerus; A F G Leentjens; F Buntinx
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

Review 5.  Prevalence and treatment of depression in Parkinson's disease.

Authors:  Connie Veazey; Sahinde Ozlem Erden Aki; Karon F Cook; Eugene C Lai; Mark E Kunik
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

6.  Depression in Parkinson's disease: clinical correlates and outcome.

Authors:  A Rojo; M Aguilar; M T Garolera; E Cubo; I Navas; S Quintana
Journal:  Parkinsonism Relat Disord       Date:  2003-10       Impact factor: 4.891

Review 7.  Depression in Parkinson's disease: a psychosocial viewpoint.

Authors:  R Brown; M Jahanshahi
Journal:  Adv Neurol       Date:  1995

Review 8.  Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.

Authors:  David J Burn
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

9.  Anxiety disorders in patients with Parkinson's disease.

Authors:  M B Stein; I J Heuser; J L Juncos; T W Uhde
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

10.  "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.

Authors:  A Vázquez; F J Jiménez-Jiménez; P García-Ruiz; D García-Urra
Journal:  Acta Neurol Scand       Date:  1993-01       Impact factor: 3.209

View more
  10 in total

1.  Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder.

Authors:  Thomas G Schulze; Nirmala Akula; René Breuer; Jo Steele; Michael A Nalls; Andrew B Singleton; Franziska A Degenhardt; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Francis J McMahon
Journal:  World J Biol Psychiatry       Date:  2012-03-09       Impact factor: 4.132

2.  Motivational engagement in Parkinson's disease: Preparation for motivated action.

Authors:  J B Renfroe; M M Bradley; M S Okun; D Bowers
Journal:  Int J Psychophysiol       Date:  2015-12-01       Impact factor: 2.997

Review 3.  Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines.

Authors:  Michael J Aminoff; Chad W Christine; Joseph H Friedman; Kelvin L Chou; Kelly E Lyons; Rajesh Pahwa; Bastian R Bloem; Sotirios A Parashos; Catherine C Price; Irene A Malaty; Robert Iansek; Ivan Bodis-Wollner; Oksana Suchowersky; Wolfgang H Oertel; Jorge Zamudio; Joyce Oberdorf; Peter Schmidt; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2010-12-14       Impact factor: 4.891

4.  [Progressive supranuclear palsy: living environment of the patients in Germany].

Authors:  M Hensler; S Paul; C Abright; S Lorenzl
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 5.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 6.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

7.  Treatment of dementia with lewy bodies.

Authors:  Brendon P Boot; Eric M McDade; Scott M McGinnis; Bradley F Boeve
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

8.  Patterns of multimorbidity in the aged population. Results from the KORA-Age study.

Authors:  Inge Kirchberger; Christa Meisinger; Margit Heier; Anja-Kerstin Zimmermann; Barbara Thorand; Christine S Autenrieth; Annette Peters; Karl-Heinz Ladwig; Angela Döring
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

9.  Reformulating psychological difficulties in people with Parkinson's disease: the potential of a social relational approach to disablism.

Authors:  Jane Simpson; Helen McMillan; Donna Reeve
Journal:  Parkinsons Dis       Date:  2013-08-13

10.  Neural cell adhesion molecule Negr1 deficiency in mouse results in structural brain endophenotypes and behavioral deviations related to psychiatric disorders.

Authors:  Katyayani Singh; Mohan Jayaram; Maria Kaare; Este Leidmaa; Toomas Jagomäe; Indrek Heinla; Miriam A Hickey; Allen Kaasik; Michael K Schäfer; Jürgen Innos; Kersti Lilleväli; Mari-Anne Philips; Eero Vasar
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.